Podcast
Questions and Answers
What is the definition of immunogenicity?
Which section of the FDA-approved label contains information about immunogenicity?
What is a characteristic of binding anti-drug antibodies (ADA)?
What is one of the consequences of neutralizing anti-drug antibodies?
Signup and view all the answers
Why is the study of immunogenicity important in biotherapeutics?
Signup and view all the answers
What are immune-privileged sites primarily designed to protect?
Signup and view all the answers
Why is immune privilege in the testis crucial for male fertility?
Signup and view all the answers
How does the mother typically tolerate the presence of fetal antigens during pregnancy?
Signup and view all the answers
What role do self antigens play in the context of immune privilege in the testis?
Signup and view all the answers
Which of the following factors contributes to immune privilege in the placenta?
Signup and view all the answers
What are examples of 'clearing' ADA based on their effects?
Signup and view all the answers
What is indicated by the development of ADA in terms of plasma drug concentration?
Signup and view all the answers
How are non-clearing ADA commonly described?
Signup and view all the answers
Which type of T cells promote ADA generation?
Signup and view all the answers
What is considered a driver of immunogenic response in T cells?
Signup and view all the answers
What is the role of Treg cells in relation to ADA?
Signup and view all the answers
What are T cell epitopes and Tregitopes related to?
Signup and view all the answers
What is a typical expectation concerning plasma drug concentrations with multiple dosing?
Signup and view all the answers
What role do dendritic cells (DCs) play in the lamina propria?
Signup and view all the answers
Which cytokines are important for the differentiation of bacterial antigen-specific Th17 cells?
Signup and view all the answers
What promotes the differentiation of bacterial antigen-specific regulatory T cells (Tregs)?
Signup and view all the answers
How do keratinocytes contribute to the immune response in the epidermis?
Signup and view all the answers
Where do the skin-homing properties of effector lymphocytes develop?
Signup and view all the answers
Which signaling factors are involved in the migration of effector T cells into the skin?
Signup and view all the answers
What is the primary function of the epidermis in relation to microbes?
Signup and view all the answers
What initiates the expression of CCR10 in the skin?
Signup and view all the answers
What is the role of intestinal epithelial cells in the gastrointestinal immune system?
Signup and view all the answers
Where are M cells primarily located within the gut?
Signup and view all the answers
What distinguishes M cells from absorptive epithelial cells?
Signup and view all the answers
What characteristic role do the lymphocytes play following their differentiation in lymphoid tissues?
Signup and view all the answers
What type of tissues induce dendritic cells in the gut?
Signup and view all the answers
What is the primary composition of the gastrointestinal system's structure?
Signup and view all the answers
Which of the following statements about M cells is true?
Signup and view all the answers
What function does the lamina propria serve in relation to the epithelial layer?
Signup and view all the answers
Study Notes
Immunogenicity
- Immunogenicity is the host immune response against a therapeutic protein
- Typically, immunogenicity is studied in the context of anti-drug antibody (ADA) formation
- All FDA-approved biotherapeutics include a section on immunogenicity in their label (section 6.2) under Adverse Reactions
Anti-Drug Antibodies
- There are two main classes of ADAs: binding and neutralizing
- Binding ADAs interact with the drug molecule but do not inhibit its binding to the pharmacologic target
- Binding ADAs may impact pharmacokinetics and safety
Neutralizing ADAs
- Neutralizing ADAs directly block the interaction of a drug with its pharmacologic target
- Neutralizing ADAs result in loss of efficacy, impact pharmacokinetics, and may impact safety
'Clearing' ADAs
- Both binding and neutralizing ADAs can be categorized as 'clearing'
- 'Clearing' ADAs are detected based on their effects on pharmacokinetics
- Non-clearing ADAs are also referred to as 'sustaining' ADAs
- A typical expectation is a rapid decrease in plasma drug concentrations upon ADA development
- Decreased plasma concentrations following multiple dosing (typical expectation is accumulation)
Physiologic Drivers of Immunogenicity
- Immunogenicity is largely thought to be a T-cell dependent phenomenon
- The context of presentation to T cells is likely a driver of the ultimate response
- Presentation to T helper cells leads to ADA generation
- Presentation to Treg cells limits ADA generation
The Gastrointestinal Immune System
- Intestinal epithelial cells lining the small and large bowel are part of the gastrointestinal innate immune system involved in responses to pathogens and antigen sampling
- The gastrointestinal system is a tube-like structure lined by a continuous epithelial cell layer that serves as a physical barrier
- The lamina propria underlies the epithelium, containing blood vessels, lymphatic vessels, and MALTs
M Cells
- M cells are located in regions of the gut epithelium called follicle-associated (or dome) epithelium
- Antigen may be delivered from the lumen to the GALT through specialized cells called M cells
- M cells have a thin glycocalyx, short irregular microvilli, and large fenestrations in their membranes, enhancing antigen uptake from the gut lumen
Homing Properties of Intestinal Lymphocytes
- The gut-homing properties of effector lymphocytes are imprinted in lymphoid tissues
- DCs in GALT are induced by cytokines
- DCs in the lamina propria take up and process protein antigens from microbes and transport them to mesenteric lymph nodes
Effector and Regulatory T Cells in the Intestinal Mucosa
- Different subsets of effector CD4+ T cells in the gastrointestinal tract are induced by and protect against different microbial species
- Th17 effector T cells and regulatory T cells are abundant in the intestinal mucosa
- Bacterial antigen-specific Th17 cells differentiate from naive CD4+ T cells in GALT in response to antigens presented by DCs
- Differentiation of bacterial antigen-specific regulatory T cells is promoted by TGF-β and retinoic acid
- Thymic Tregs that migrate to the intestine expand under the influence of bacterial metabolites
The Cutaneous Immune System
- The epidermis provides a physical barrier to microbial invasion
- The epidermis is made up of keratinocytes
- Keratinocytes actively respond to pathogens by producing antimicrobial peptides and cytokines
Homing Properties of Cutaneous Lymphocytes
- The skin-homing properties of effector lymphocytes are imprinted in skin-draining lymph nodes
- Ultraviolet rays in sunlight stimulate vitamin D production
- IL-12 induces the expression of E-selectin ligand CLA, and other signals induce CCR4, CCR8, and CCR10 expression
Immune-Privileged Tissues
- Immune responses and associated inflammation in certain parts of the body, including brain, eye, testes, placenta, and fetus, carry a high risk for lethal organ dysfunction
- These tissues are called immune-privileged sites
Immune Privilege in the Testis
- Immune privilege in the testes limits inflammation that may impair male fertility
- Many self-antigens in the testes are first expressed at puberty, so it is unlikely lymphocytes specific for these antigens are deleted during development
- Immune privilege in the testes may also prevent autoimmunity
Immune Privilege and the Fetus
- The fetus expresses paternally inherited genes that are foreign to the mother
- The mother is exposed to fetal antigens during pregnancy, and maternal antibodies against paternal MHC molecules are detectable
- Different molecular and barrier features of the placenta contribute to immune privilege in the fetus
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores the concepts of immunogenicity, focusing on the immune responses to therapeutic proteins. It covers the different classes of anti-drug antibodies, including binding and neutralizing antibodies, as well as their implications on pharmacokinetics and drug efficacy. Understanding these mechanisms is crucial for evaluating the safety and effectiveness of biotherapeutics.